The abstract is read at the publisher; the summary is JClub's.
Dysbiosis across gut, oral, skin, and cervicovaginal microbiomes is linked to non-communicable diseases and may contribute mechanistically, but strong interindividual and disease-specific variability persists.
- Why it matters: The field needs clearer causal mechanisms and reproducible biomarkers, because current evidence is largely associative and clinical efficacy for many microbiome interventions is not yet established.
- What they did: This review synthesizes evidence on epithelial barrier dysfunction, altered microbial metabolite signaling, innate immune activation, inflammatory signaling, and immune dysregulation, and evaluates microbiome-based diagnostics and therapies.
- The result: It supports translational potential for diagnostics, fecal microbiota transplantation, personalized nutrition, and microbial therapeutics, while calling for rigorously designed interventional and longitudinal multi-omics studies with host genetics and immune phenotyping.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.